Slide 1: 2026 Investor Conference
CORPORATE PRESENTATION 2026 Investor Conference Nextronics Engineering Corp. NEXTRON · Stock Code 8147
Slide 2: Disclaimer
DISCLAIMER Disclaimer 1. This presentation may contain forward-looking statements. Such statements are based on current expectations and are subject to known and unknown risks and uncertainties; actual results may differ materially from those expressed or implied. 2. Except as required by law, the C
Slide 3: Agenda
AGENDA Agenda 01 02 03 04 Company Overview Financials Operations Outlook 40 YEARS OF GROWTH 1H 2026 RESULTS REVENUE & CAPACITY MARKETS & 2027 PLAN © 2026 Nextronics Engineering Corp. reserved
Slide 4: Company Overview
01 Company Overview 40 YEARS OF GROWTH NSXtrON
Slide 5: Company Overview: From Survival to Legacy and a Second Growth Curve
COMPANY OVERVIEW 40 Years: From Survival to Legacy and a Second Growth Curve STAGE 01 STAGE 02 STAGE 03 STAGE 04 Survival Growth Transformation Legacy & Second Curve © 2026 Nextronics Engineering Corp. reserved
Slide 6: Financials
02 Financials 1H 2026 RESULTS NSXtrON
Slide 7: 1H 2026 Financial Performance
© 2026 Nextronics Engineering Corp. reserved FINANCIALS 1H 2026 Financial Performance
Slide 8: Operations
03 Operations REVENUE & CAPACITY NSXtrON
Slide 9: Jan–Aug 2026 Revenue & Product Mix
OPERATIONS Jan–Aug 2026 Revenue & Product Mix Revenue Trend Products Portfolio Monthly Consolidated Revenue (Jan–Aug) Product Mix (Jan–Aug) 2025 / 2026 Revenue (Jan. ~ Aug.) 2.5 NT$ thousand Jan–Aug 2026 % Jan–Aug 2025 % 2 Connectors 961,421 69% 654,831 60% 1.5 Sub-System 363,354 26% 362,991 33% © 2
Slide 10: Jan–Aug 2026 Revenue by Application Market
OPERATIONS Jan–Aug 2026 Revenue by Application Market Others 0.1% Medical Application Market 2026 Share 2025 Share 30.7% Medical 30.7% 27.5% Aerospace 2.9% 3.3% Communication 44.3% Transportation 3.0% 2.3% Industrial 19.0% 18.8% © 2026 Nextronics Engineering Corp. reserved Aerospace Communication 44
Slide 11: Global Capacity Readiness
OPERATIONS Global Capacity Readiness • 2025–26: Capacity realigned for product transition and geopolitics • Jan–Aug 2026: Global sites built out, staffed and customer-qualified Level 1: Component Manufacturing Guangzhou Plant New Taipei Plant • Lv5 line: MP in Q4 • Medical line certified • +1,320 m²
Slide 12: Outlook
Outlook MARKETS & 2027 PLAN NSXtrON
Slide 13: Deepening Our Focus on EP Ablation
© 2026 Nextronics Engineering Corp. reserved MEDICAL Deepening Our Focus on EP Ablation
Slide 14: Humanoid Robots: Growth Potential Multiplying
INDUSTRY Humanoid Robots: Growth Potential Multiplying © 2026 Nextronics Engineering Corp. reserved
Slide 15: 800G to 12.8T Roadmap
© 2026 Nextronics Engineering Corp. reserved COMMUNICATION 800G to 12.8T Roadmap
Slide 16: Future Outlook
2027 OUTLOOK Future Outlook Sustained R&D to Build a Second Curve Expanding Depth & Breadth in Growth Markets R&D and product development staff are nearly a quarter of our Going beyond connectors, we invest boldly alongside key workforce, engaging us in AI, advanced medical, humanoid customers to ca
Slide 17: Questions
Q&A Questions Welcome NSXtrON
Slide 18: Nextron
www.nextrongroup.com Nextron